| 0 |
MYELOCYTE PERCENTAGE DECREASED |
1 |
0.3333 |
| 1 |
PULMONARY VENOUS HYPERTENSION |
1 |
0.0769 |
| 2 |
MYELOCYTE COUNT DECREASED |
1 |
0.0714 |
| 3 |
CANCER SCREENING ABNORMAL |
1 |
0.0526 |
| 4 |
PSEUDOMONAS PERITONITIS |
1 |
0.0278 |
| 5 |
PLASMA CELLS INCREASED |
1 |
0.0137 |
| 6 |
PATERNAL DRUGS AFFECTING FOETUS |
1 |
0.0027 |
| 7 |
MARROW HYPERPLASIA |
1 |
0.0015 |
| 8 |
OESOPHAGITIS ULCERATIVE |
1 |
0.0015 |
| 9 |
PREGNANCY OF PARTNER |
1 |
0.0014 |
| 10 |
LYMPHOCYTE PERCENTAGE DECREASED |
1 |
0.0007 |
| 11 |
NON-CARDIAC CHEST PAIN |
2 |
0.0006 |
| 12 |
PLASMACYTOMA |
1 |
0.0005 |
| 13 |
EOSINOPHIL COUNT DECREASED |
1 |
0.0004 |
| 14 |
STEM CELL TRANSPLANT |
1 |
0.0004 |
| 15 |
URINARY TRACT INFECTION BACTERIAL |
1 |
0.0004 |
| 16 |
BILIARY COLIC |
1 |
0.0003 |
| 17 |
STRIDOR |
1 |
0.0003 |
| 18 |
ARTHRITIS BACTERIAL |
1 |
0.0002 |
| 19 |
ILEUS PARALYTIC |
1 |
0.0002 |
| 20 |
VIRAL UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0002 |
| 21 |
PATHOLOGICAL FRACTURE |
1 |
0.0002 |
| 22 |
COVID-19 PNEUMONIA |
2 |
0.0002 |
| 23 |
HYPOGAMMAGLOBULINAEMIA |
1 |
0.0002 |
| 24 |
NEUTROPHIL COUNT DECREASED |
5 |
0.0001 |
| 25 |
INFUSION SITE ERYTHEMA |
1 |
0.0001 |
| 26 |
ANAL INCONTINENCE |
1 |
0.0001 |
| 27 |
UROSEPSIS |
1 |
0.0001 |
| 28 |
NEUTROPHIL COUNT INCREASED |
1 |
0.0001 |
| 29 |
HYPERTENSIVE CRISIS |
1 |
0.0001 |
| 30 |
UPPER RESPIRATORY TRACT INFECTION |
4 |
0.0001 |
| 31 |
BACTERAEMIA |
1 |
0.0001 |
| 32 |
CYTOPENIA |
1 |
0.0001 |
| 33 |
RESPIRATORY DEPRESSION |
1 |
0.0001 |
| 34 |
ILEUS |
1 |
0.0001 |
| 35 |
SARS-COV-2 TEST POSITIVE |
1 |
0.0001 |
| 36 |
TACHYPNOEA |
1 |
0.0001 |
| 37 |
NEUTROPENIA |
9 |
0.0001 |
| 38 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 39 |
SENSORY DISTURBANCE |
1 |
0.0001 |
| 40 |
URINARY RETENTION |
2 |
0.0001 |
| 41 |
PELVIC PAIN |
1 |
0.0001 |
| 42 |
PLASMA CELL MYELOMA |
2 |
0.0001 |
| 43 |
CYTOKINE RELEASE SYNDROME |
1 |
0.0000 |
| 44 |
FULL BLOOD COUNT DECREASED |
1 |
0.0000 |
| 45 |
RETCHING |
1 |
0.0000 |
| 46 |
INFUSION RELATED REACTION |
3 |
0.0000 |
| 47 |
TOOTH DISORDER |
1 |
0.0000 |
| 48 |
HYPOKALAEMIA |
2 |
0.0000 |
| 49 |
OSTEONECROSIS OF JAW |
1 |
0.0000 |
| 50 |
CELLULITIS |
2 |
0.0000 |
| 51 |
DIPLOPIA |
1 |
0.0000 |
| 52 |
SKIN LESION |
1 |
0.0000 |
| 53 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 54 |
ANAPHYLACTIC REACTION |
2 |
0.0000 |
| 55 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 56 |
URINARY TRACT INFECTION |
6 |
0.0000 |
| 57 |
HAEMATURIA |
1 |
0.0000 |
| 58 |
DELIRIUM |
1 |
0.0000 |
| 59 |
NEOPLASM PROGRESSION |
1 |
0.0000 |
| 60 |
HYPOXIA |
1 |
0.0000 |
| 61 |
PLATELET COUNT DECREASED |
3 |
0.0000 |
| 62 |
MYELOSUPPRESSION |
1 |
0.0000 |
| 63 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 64 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 65 |
SEPTIC SHOCK |
1 |
0.0000 |
| 66 |
RENAL DISORDER |
1 |
0.0000 |
| 67 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 68 |
LEUKOPENIA |
1 |
0.0000 |
| 69 |
WHITE BLOOD CELL COUNT DECREASED |
2 |
0.0000 |
| 70 |
OEDEMA |
1 |
0.0000 |
| 71 |
THROMBOCYTOPENIA |
2 |
0.0000 |
| 72 |
HERPES ZOSTER |
1 |
0.0000 |
| 73 |
CATARACT |
1 |
0.0000 |
| 74 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 75 |
AMNESIA |
1 |
0.0000 |
| 76 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 77 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 78 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 79 |
ABDOMINAL PAIN |
3 |
0.0000 |
| 80 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 81 |
COVID-19 |
2 |
0.0000 |
| 82 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
2 |
0.0000 |
| 83 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 84 |
CHEST PAIN |
2 |
0.0000 |
| 85 |
DYSPHAGIA |
1 |
0.0000 |
| 86 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 87 |
ANAEMIA |
2 |
0.0000 |
| 88 |
GAIT DISTURBANCE |
2 |
0.0000 |
| 89 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 90 |
HYPOTENSION |
2 |
0.0000 |
| 91 |
FLUSHING |
1 |
0.0000 |
| 92 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 93 |
PNEUMONIA |
3 |
0.0000 |
| 94 |
INFLUENZA |
1 |
0.0000 |
| 95 |
SEPSIS |
1 |
0.0000 |
| 96 |
SEIZURE |
1 |
0.0000 |
| 97 |
CHILLS |
1 |
0.0000 |
| 98 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 99 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 100 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 101 |
RENAL FAILURE |
1 |
0.0000 |
| 102 |
DEHYDRATION |
1 |
0.0000 |
| 103 |
WEIGHT DECREASED |
2 |
0.0000 |
| 104 |
MALAISE |
3 |
0.0000 |
| 105 |
CONDITION AGGRAVATED |
2 |
0.0000 |
| 106 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 107 |
PARAESTHESIA |
1 |
0.0000 |
| 108 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 109 |
PYREXIA |
2 |
0.0000 |
| 110 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 111 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 112 |
HEADACHE |
3 |
0.0000 |
| 113 |
HYPERTENSION |
1 |
0.0000 |
| 114 |
CONSTIPATION |
1 |
0.0000 |
| 115 |
WEIGHT INCREASED |
1 |
0.0000 |
| 116 |
BACK PAIN |
1 |
0.0000 |
| 117 |
DIZZINESS |
2 |
0.0000 |
| 118 |
INSOMNIA |
1 |
0.0000 |
| 119 |
DYSPNOEA |
2 |
0.0000 |
| 120 |
OFF LABEL USE |
3 |
0.0000 |
| 121 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 122 |
FALL |
1 |
0.0000 |
| 123 |
FATIGUE |
2 |
0.0000 |
| 124 |
NAUSEA |
2 |
0.0000 |
| 125 |
DEATH |
2 |
0.0000 |
| 126 |
RASH |
1 |
0.0000 |
| 127 |
DIARRHOEA |
1 |
0.0000 |
| 128 |
DRUG INEFFECTIVE |
1 |
0.0000 |